2019 Grand Rounds Archive
Liver Regeneration Strategies in Interventional Oncology: portal vein embolization and beyond
David Madoff, MD, FSIR, FACR, FCIRSE
Yale Cancer Center Grand Rounds
December 10, 2019
Cancer Genomics: Evaluating the Overall Impact of Passenger Mutations
Mark Gerstein, PhD
Yale Cancer Center Grand Rounds
December 3, 2019
Cancer Control in the 21st Century
Calabresi Lecture/Yale Cancer Center Grand Rounds | November 19, 2019
Otis W. Brawley, MD, MACP, FASCO, FACE
Genomic Profiling, Big Data, and Machine Learning Drive Precision Cancer Care
Marilyn M. Li, MD, Professor of Pediatrics and Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine; Vice Chief, Division of Genomic Diagnostics and Director of Cancer Genomic Diagnostics, Children's Hospital of Philadelphia
Yale Cancer Center Grand Rounds | November 12, 2019
Implementation Science in Cancer Prevention, Screening and Treatment: The Why, What and How?
Donna Spiegelman, ScD Susan Dwight Bliss Professor of Biostatistics, Yale School of Public Health; Assistant Cancer Center Director, Global Oncology, Yale Cancer Center
Yale Cancer Center Grand Rounds | November 5, 2019
Community-engaged Research with Faith-based Communities: How to create long-standing partnerships
Lorna H. McNeill, PhD, MPH
Yale Cancer Center Grand Rounds
October 29, 2019
Improving End-of-Life Care Quality for Children with Cancer
Prasanna Ananth, MD, MPH
Yale Cancer Center Grand Rounds
October 22, 2019
Obesity and Cancer: How Can We Break the Link?
Rachel Perry, PhD
Yale Cancer Center Grand Rounds
October 22, 2019
The State of Yale Cancer Center and Smilow Cancer Hospital, an update for 2019-2020
Charles Fuchs, MD, MPH
Yale Cancer Center Grand Rounds
October 15, 2019
Addressing Physician Well-Being in an Academic Medical Practice
Marcela G. del Carmen, MD, MPH
Yale Cancer Center Grand Rounds
October 8, 2019
Tertiary Lymphoid Structures in Cancer
Joseph Craft, MD
Yale Cancer Center Grand Rounds
October 1, 2019
Deriving Imaging Based Biomarkers for Non-Small Cell Lung Cancer Patients Using Deep Learning
Sanjay Aneja, MD
Yale Cancer Center Grand Rounds
October 1, 2019
Genetically-modified Cell Therapies: The next wave in immuno-oncology
Joseph Bove Lecture/YCC Grand Rounds
September 24, 2019
Provider Volume and Cancer Outcomes: Moving beyond surgical settings and into the increasingly complex field of medical oncology
Yale Cancer Center Grand Rounds | September 17, 2019
Scott Huntington, MD, MPH Assistant Professor of Medicine, Yale School of Medicine
DBiT-seq for High-Spatial-Resolution Multi-Omics Profiling
Yale Cancer Center Grand Rounds | September 17, 2019
Rong Fan, PhD Associate Professor of Biomedical Engineering, Yale School of Medicine
Ten Years of HPV Vaccine Impact Monitoring: Lessons Learned and Future Directions
Yale Cancer Center Grand Rounds
September 10, 2019
Linda Niccolai, PhD
Exploiting Unexpected NAD Metabolic Vulnerabilities in PPM1D-mutant Gliomas
Yale Cancer Center Grand Rounds
September 10, 2019
Ranjit Bindra, MD, PhD
Slow and Steady Wins the Race? Epigenetic therapy in solid tumors
Yale Cancer Center Grand Rounds | June 25, 2019
DNA Repair Variants and Cancer
Yale Cancer Center Grand Rounds | June 18, 2019
Joann Sweasy, PhD, Ensign Professor of Therapeutic Radiology and Professor of Genetics
Oncogenic Herpesviruses: New Insights into Mechanisms Regulating Synthesis of Viral Structural Proteins
Yale Cancer Center Grand Rounds | June 11, 2019
Ayman El-Guindy, PhD, Associate Professor of Pediatrics (Infectious Disease), Yale School of Medicine
Challenges and Opportunities in Brain Tumors
Yale Cancer Center Grand Rounds | May 28, 2019 Antonio Omuro, MDLiquid Phase Separation and Cancer
Yale Cancer Center Grand Rounds | May 28, 2019 Karla Neugebauer, PhDFinancial Conflicts in Cancer Research & Practice: Where Do We Stand in 2019?
Yale Cancer Center Grand Rounds | May 21, 2019 Cary Gross, MDCombining Radiation and Immune Checkpoint Inhibitors in NSCLC
Yale Cancer Center Grand Rounds | May 21, 2019 Roy Decker, MD, PhDColorectal Cancer: From Disparities to a New Molecular Subtype Associated with Early Age Onset
Yale Cancer Center Grand Rounds | May 14, 2019 Xavier Llor, MD, PhDGene Editing Applications in Oncology and Immuno-Oncology
Yale Cancer Center Grand Rounds | May 14, 2019 Sidi Chen, PhDCombining Radiation and Immune Checkpoint Inhibitors in NSCLC
Yale Cancer Center Grand Rounds | May 21, 2019 Roy Decker, MD, PhDTargeting Amplified Gene Loci as a Pro-Apoptotic Anticancer Therapy
Yale Cancer Center Grand Rounds | April 30, 2019Tumor Hypoxia and Regulation of Cancer Cell Stemness
Yale Cancer Center Grand Rounds | April 30, 2019Biostatistics Shared Resource
April 23, 2019: Yale Cancer Center Grand Rounds with Shuangge (Steven) Ma,Cervical Cancer Prevention in Low Resource Settings - An Experience from Nepal
April 23, 2019: Yale Cancer Center Grand Rounds with Archana Shrestha, PhD, Dhulikhel Hospital, Kathmandu University HospitalAdvances in Prostate Cancer Radiotherapy
Yale Cancer Center Grand Rounds | April 9, 2019Yale Cancer Center Grand Rounds | March 26, 2019
YCC Functional Genomics Core David Calderwood, PhDYale Cancer Center Grand Rounds | March 26, 2019
Yale Flow Cytometry Facility Ann Haberman, PhDYale Cancer Center Grand Rounds | March 19, 2019
Stephan Grupp, MD, PhD, Director of Cancer Immunotherapy and Cell Therapy/Transplant Section, Children's Hospital of Philadelphia, Perelman School of Medicine at the University of PennsylvaniaYale Cancer Center Grand Rounds | March 5, 2019
NCI #10020 - Olaparib Alone or in Combination with Atezolizumab in the Treatment of Patients with HER2- BRCAmt Breast Cancer: From Bench to Bedside and Back - Patricia LoRusso, DO, PhDHuman Natural Killer Cells: From Bench to Clinic
Yale Cancer Center Grand Rounds | February 12, 2019Sex-specific differences in colorectal cancer metabolism
Women have a lower risk of colorectal cancer than men, but a higher prevalence for tumor presentation in an area of the colon that has poorer clinical outcomes.Clinical Research Support Laboratory – How We make Research Happen
The CRSL is an important part of the clinical trials operations that not many people are aware of.Molecular Hallmarks of Tumor-Stromal Interactions in Brain Metastasis
Learn how to leverage different approaches and models to study human brain metastasis and define the transcriptomic landscape of brain metastasis in situHuman Papillomavirus: from basic mechanisms to a new antiviral paradigm
Yale Cancer Center Grand Rounds | January 29, 2019Preventing HPV-associated Cancers by Vaccination
Yale Cancer Center Grand Rounds | January 22, 2019